Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」

• Status: Completed
• Trial end date: 2013-04-25
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to gain an understanding of the actual use of candesartan cilexetil (Blopress) in patients with hypertension, and to examine the changes in parameters such as blood pressure.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Takeda
• Treatments: Candesartan; Candesartan cilexetil

Criteria

Inclusion Criteria:

• Hypertensive patients

Exclusion Criteria:

1. Inpatients

2. Patients under dialysis (planned)

3. Patients with a history of coronary artery disease/cerebrovascular disorder within 6 months

4. Patients with ≥ class III of the New York Heart Association (NYHA) classification functional classification of heart failure

5. Patients that have been prescribed with candesartan (this drug/Ecard/Unisia) in the past

6. Patients who are pregnant or may possibly become pregnant